CymaBay Secures $100M Non-Dilutive Funding To Fund Seladelpar Development Program

  • CymaBay Therapeutics Inc CBAY has received $100 million in non-dilutive financing from Abingworth to fund the Phase 3 development program for seladelpar in primary biliary cholangitis (PBC).
  • Under the terms of the transaction, CymaBay will receive up to $100 million of seladelpar development costs, of which $75 million will be received in three installments over approximately six months. 
  • CymaBay has an option to receive a further $25 million within approximately two months after completing enrollment in its Phase 3 RESPONSE trial. 
  • In exchange, CymaBay will make fixed payments spread over six years based on regulatory approval in the U.S. or the E.U. after the first such regulatory approval is obtained and pay fixed and capped sales milestones based on U.S. product sales. 
  • CymaBay is currently dosing patients in its Phase 3 RESPONSE clinical trial and its ASSURE open-label extension trial and other Phase 1 NDA-enabling clinical studies.
  • Seladelpar is a first-in-class oral, selective PPARδ agonist shown to regulate critical metabolic and liver disease pathways.
  • Price Action: CBAY shares are down 0.89% at $3.91 during the market session on the last check Monday.

Posted In: Briefssclerosing cholangitisBiotechNewsPenny StocksHealth CareFinancingGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.